237 related articles for article (PubMed ID: 21802007)
1. Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate.
Velásquez JE; Zhang X; van der Donk WA
Chem Biol; 2011 Jul; 18(7):857-67. PubMed ID: 21802007
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7.
van de Kamp M; van den Hooven HW; Konings RN; Bierbaum G; Sahl HG; Kuipers OP; Siezen RJ; de Vos WM; Hilbers CW; van de Ven FJ
Eur J Biochem; 1995 Jun; 230(2):587-600. PubMed ID: 7607233
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of the lanthipeptide peptidase ElxP and the oxidoreductase ElxO.
Ortega MA; Velásquez JE; Garg N; Zhang Q; Joyce RE; Nair SK; van der Donk WA
ACS Chem Biol; 2014 Aug; 9(8):1718-25. PubMed ID: 24866416
[TBL] [Abstract][Full Text] [Related]
4. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.
Ekkelenkamp MB; Hanssen M; Danny Hsu ST; de Jong A; Milatovic D; Verhoef J; van Nuland NA
FEBS Lett; 2005 Mar; 579(9):1917-22. PubMed ID: 15792796
[TBL] [Abstract][Full Text] [Related]
5. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.
Bierbaum G; Götz F; Peschel A; Kupke T; van de Kamp M; Sahl HG
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):119-127. PubMed ID: 8775972
[TBL] [Abstract][Full Text] [Related]
6. Control of antimicrobial peptide synthesis by the agr quorum sensing system in Staphylococcus epidermidis: activity of the lantibiotic epidermin is regulated at the level of precursor peptide processing.
Kies S; Vuong C; Hille M; Peschel A; Meyer C; Götz F; Otto M
Peptides; 2003 Mar; 24(3):329-38. PubMed ID: 12732329
[TBL] [Abstract][Full Text] [Related]
7. Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X.
Knerr PJ; van der Donk WA
J Am Chem Soc; 2012 May; 134(18):7648-51. PubMed ID: 22524291
[TBL] [Abstract][Full Text] [Related]
8. Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7.
van de Kamp M; Horstink LM; van den Hooven HW; Konings RN; Hilbers CW; Frey A; Sahl HG; Metzger JW; van de Ven FJ
Eur J Biochem; 1995 Feb; 227(3):757-71. PubMed ID: 7867636
[TBL] [Abstract][Full Text] [Related]
9. Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.
Basi-Chipalu S; Dischinger J; Josten M; Szekat C; Zweynert A; Sahl HG; Bierbaum G
Appl Environ Microbiol; 2015 May; 81(10):3419-29. PubMed ID: 25769830
[TBL] [Abstract][Full Text] [Related]
10. [Lantibiotics, a class of ribosomally synthesized peptide antibiotics].
Entian KD; Klein C
Naturwissenschaften; 1993 Oct; 80(10):454-60. PubMed ID: 8264800
[TBL] [Abstract][Full Text] [Related]
11. Expression, purification, and characterization of EpiC, an enzyme involved in the biosynthesis of the lantibiotic epidermin, and sequence analysis of Staphylococcus epidermidis epiC mutants.
Kupke T; Gotz F
J Bacteriol; 1996 Mar; 178(5):1335-40. PubMed ID: 8631710
[TBL] [Abstract][Full Text] [Related]
12. Effect of leader peptide mutations on biosynthesis of the lantibiotic Pep5.
Neis S; Bierbaum G; Josten M; Pag U; Kempter C; Jung G; Sahl HG
FEMS Microbiol Lett; 1997 Apr; 149(2):249-55. PubMed ID: 9141666
[TBL] [Abstract][Full Text] [Related]
13. The enigmatic mode of action of the lantibiotic epilancin 15X.
Wang X; Xu Y; Martin NI; Breukink E
Biochim Biophys Acta Biomembr; 2024 Mar; 1866(3):184282. PubMed ID: 38218577
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis and transport of the lantibiotic mutacin 1140 produced by Streptococcus mutans.
Escano J; Stauffer B; Brennan J; Bullock M; Smith L
J Bacteriol; 2015 Apr; 197(7):1173-84. PubMed ID: 25605307
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation.
Meyer C; Bierbaum G; Heidrich C; Reis M; Süling J; Iglesias-Wind MI; Kempter C; Molitor E; Sahl HG
Eur J Biochem; 1995 Sep; 232(2):478-89. PubMed ID: 7556197
[TBL] [Abstract][Full Text] [Related]
16. The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics.
Escano J; Stauffer B; Brennan J; Bullock M; Smith L
Microbiologyopen; 2014 Dec; 3(6):961-72. PubMed ID: 25400246
[TBL] [Abstract][Full Text] [Related]
17. Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides.
Claesen J; Bibb M
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16297-302. PubMed ID: 20805503
[TBL] [Abstract][Full Text] [Related]
18. Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster.
Heidrich C; Pag U; Josten M; Metzger J; Jack RW; Bierbaum G; Jung G; Sahl HG
Appl Environ Microbiol; 1998 Sep; 64(9):3140-6. PubMed ID: 9726851
[TBL] [Abstract][Full Text] [Related]
19. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of genetically engineered gallidermin and epidermin analogs.
Ottenwälder B; Kupke T; Brecht S; Gnau V; Metzger J; Jung G; Götz F
Appl Environ Microbiol; 1995 Nov; 61(11):3894-903. PubMed ID: 8526502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
